
NICE backs Axhidrox for severe underarm sweating
First guidance for a licensed hyperhidrosis treatment
in-depth news, features and insights for the pharmaceutical and healthcare sectors
Live Last read · last published · next check

First guidance for a licensed hyperhidrosis treatment

Company receives USD 10 million upfront

Partnership expands access to men’s health treatment

Saffron trial delivers positive results

Phase 3 study shows strong efficacy

Rigel makes Veppanu available across US

Study begins testing KJ‑103 in TROP2‑positive cancers

New alliance aims to accelerate development of future medicines

KUP101 enters clinic for advanced solid tumours

SMC acceptance offers new option for patients